BridgeBio Pharma (BBIO) Share-based Compensation (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Share-based Compensation (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.84% |
| Dec 31, 2025 | -365.85% |
| Sep 30, 2025 | -15.22% |
| Jun 30, 2025 | 44.27% |
| Mar 31, 2025 | 1,743.45% |
| Dec 31, 2024 | -94.83% |
| Sep 30, 2024 | 26.48% |
| Jun 30, 2024 | 3,894.60% |
| Mar 31, 2024 | -98.26% |
| Dec 31, 2023 | 13.21% |
| Sep 30, 2023 | 22,976.27% |
| Jun 30, 2023 | -38.86% |
| Mar 31, 2023 | -99.15% |
| Dec 31, 2022 | 21.04% |
| Sep 30, 2022 | 33,217.86% |
| Jun 30, 2022 | -94.20% |
| Mar 31, 2022 | -96.26% |
| Dec 31, 2021 | 60.22% |
| Sep 30, 2021 | 330.02% |
| Jun 30, 2021 | 127.20% |